Berman et al (21) reported that, in 2003, 81% of digestive tract cancer cells, including esophageal, gastric, biliary and pancreatic cancer- derived cell lines, exhibit the expression of SHH and its receptor, PTCH. Here, SHH is linked to pancreatic neoplasm.